Home > Insider Trading > Filing (0001179110-20-008099)

Filing Details

Accession Number:: 0001179110-20-008099
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-07 18:25:48
Reporting Period:: 2020-07-02

Accepted Time:: 2020-07-07 18:25:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-02	3,125	$0.00	27,675	No	4	M	Direct
Common Stock	Acquisiton	2020-07-02	9,376	$13.01	37,051	No	4	M	Direct
Common Stock	Disposition	2020-07-02	5,878	$48.70	31,173	No	4	S	Direct
Common Stock	Disposition	2020-07-02	5,800	$49.42	25,373	No	4	S	Direct
Common Stock	Disposition	2020-07-06	1,559	$48.36	23,814	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2020-07-02	3,125	$0.00	3,125	$0.00
Common Stock	Stock Option (right to buy)	Disposition	2020-07-02	9,376	$0.00	9,376	$13.01

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,250			No	4	M	Direct
121,874		2020-01-10	No	4	M	Direct

Footnotes

Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting January 2, 2020.
Each RSU represents a contingent right to receive one share of the common stock of the issuer.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.22 to $49.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.247 to $50.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
The RSUs vest over four years. 25% of the RSUs vest on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of June 8, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 62,500 additional shares.